NOAEL Studies
Cosmetic Ingredient
PEG-3 2,2'-DI-P-PHENYLENEDIAMINE NOAEL Studies
CAS: 144644-13-3
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCNFP Opinion 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =10 | mg/kg bw | - | dermal | Sub-chronic | repeated dose toxicity | p.6 |
| SCCNFP Opinion | NOAEL | =45 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
| SCCNFP Opinion | NOAEL | =200 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
Regulatory source 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | dermal absorption | 45 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
| Regulatory source | dermal absorption | 200 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
| Regulatory source | irritation | 10 | mg/kg bw | rat | oral | 13 weeks | irritation | p.15 |
| Regulatory source | irritation | 200 | mg/kg bw | rat | oral | 13 weeks | irritation | p.15 |
| Regulatory source | repeated dose toxicity | 10 | mg/kg bw | - | dermal | Sub-chronic | repeated dose toxicity | p.6 |